Meta-analysis of the effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on patients with liver fibrosis showed a reduction in serum hepatic fibrosis markers such as TGF-β, TIMP-1, MMPs, and collagen (75). Here, TGFB1 is linked to Hepatic fibrosis.